Summary
Benzodiazepine drugs have been shown to suppress respiratory function in patients with chronic obstructive pulmonary disease (COPD). We designed a placebo-controlled crossover study to compare the effects of a new benzodiazepine, estazolam (‘ProSom’), with those of flurazepam (‘Dalmane’) on cardiopulmonary function in COPD patients. 29 patients completed all treatment phases (estazolam 2mg, flurazepam 30mg or placebo). Respiratory and cardiovascular function were assessed in awake patients on days 1 and 5 (acute and cumulative effects). Eight patients were also assessed during sleep in each period. The effects of estazolam and flurazepam on ventilatory response to CO2 and mouth occlusion pressure were no different from those of placebo. However, acute administration of flurazepam lowered tidal volume and increased inspiratory flow. Although no clinical signs of respiratory depression were observed with any long term treatment, flurazepam decreased oxygen saturation and inspiratory time and increased respiratory frequency. Neither drug altered breathing control during sleep. Our results indicate that estazolam 2mg is equally as safe a hypnotic agent as flurazepam for patients with mild COPD.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Abbott Laboratories. Data on file: M80-060, M81-023, M82-003, and M79-062, 1991
American Thoracic Society. Chronic bronchitis, asthma, and pulmonary emphysema. American Review of Respiratory Disease 85: 762–768, 1962
Block AJ, Dolly FR, Slayton PC. Does flurazepam ingestion affect breathing and oxygenation during sleep in patients with chronic obstructive lung disease? American Review of Respiratory Disease 129: 230–233, 1984
Cohn MA, Nay KN, Kiel M, et al. Pattern of breathing during sleep in insomniac adults. Sleep Research 12: 232, 1983
Cohn MA, Rao ASV, Broudy M, Birch S, Watson H, et al. The respiratory inductive plethysmograph: a new non-invasive monitor of respiration. Bulletin European de Physiopathologie Respiratoire 18: 643–658, 1982
Denaut M, Yernault JC, Coster A. Double-blind comparison of the respiratory effects of parenteral lorazepam and diazepam in patients with chronic obstructive lung disease. Current Medical Research and Opinion 2: 611–615, 1974
Douglas NJ, White DP, Weil JV, Pickett CK, Martin RJ, et al. Hypoxic ventilatory response decreases during sleep in normal men. American Review of Respiratory Disease 125: 286–289, 1982a
Douglas NJ, White DP, Weil JV, Pickett CK, Zwillich CW, et al. Hypercapnic ventilatory response in sleeping adults. American Review of Respiratory Disease 126: 758–762, 1982b
Geddes DM, Rudolf M, Saunders KB. Effect of nitrazepam and flurazepam on the ventilatory response to carbon dioxide. Thorax 31: 548–551, 1976
Gothe B, Cherniack NS, William L. Effect of hypoxia on ventilatory and arousal responses to CO2 during NREM sleep with and without flurazepam in young adults. Sleep 9: 24–37, 1986
Gustavson LE, Carrigan PJ. The clinical pharmacokinetics of single doses of estazolam. American Journal of Medicine 88(suppl. 3A): 2S–5S, 1990
Hedemark LL, Kronenberg RS. Flurazepam attenuates the arousal response to CO2 during sleep in normal subjects. American Review of Respiratory Disease 128: 980–983, 1983
Lamphere J, Roehrs T, Zorick F, Koshorek G, Roth T. Chronic hypnotic efficacy of estazolam. Drugs Under Experimental and Clinical Research 12: 687–691, 1986
Phillipson EA. Regulation of breathing during sleep. American Review of Respiratory Disease 115: 217–224, 1977
Pierce MW, Shu VS. Efficacy of estazolam: the United States clinical experience. American Journal of Medicine 88(suppl. 3A): 6S–11S, 1990
Pierce MW, Shu VS, Groves LJ. Safety of estazolam: the United States clinical experience. American Journal of Medicine 88(suppl. 3A): 12S–17S, 1990
Read DJC. A clinical method for assessing the ventilatory response to carbon dioxide. Australasian Annals of Medicine 16: 20–32, 1967
Rechtschaffen A, Kales A (Eds). A manual of standardized terminology, techniques and scoring systems for sleep stages of human subjects. National Institutes of Health, pub. no. 204, 1968
Spodick DH, Lance VQ. Noninvasive stress testing: methodology for elimination of the phonocardiogram. Circulation 53: 673–676, 1976
Tabachnik E, Muller NL, Bryan AC, Levison H. Changes in ventilation and chest wall mechanics during sleep in normal adolescents. Journal of Applied Physiology: Respiratory, Environmental and Exercise Physiology 51: 557–564, 1981a
Tabachnik E, Muller NL, Levison H, Bryan AC. Chest wall mechanics and pattern of breathing during sleep in asthmatic adolescents. American Review of Respiratory Disease 124: 269–273, 1981b
Tobin MJ, Cohn MA, Sackner MA. Breathing abnormalities during sleep. Archives of Internal Medicine 143: 1221–1228, 1983
Vogel GW. Effects of estazolam on sleep, performance, and memory: a long-term sleep laboratory study of elderly insomniacs. Journal of Clinical Pharmacology, in press, 1992
Widdicombe J. The effects of psychotropic drugs on respiration. In International encyclopedia of pharmacology and therapeutics; section 104: respiratory pharmacology, pp. 129–163, Pergamon Press, Oxford, 1981
Zackon H, Despas PJ, Anthonisen NR. Occlusion pressure responses in asthma and chronic obstructive pulmonary disease. American Review of Respiratory Disease 114: 917–927, 1976
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Cohn, M.A., Morris, D.D. & Juan, D. Effects of Estazolam and Flurazepam on Cardiopulmonary Function in Patients with Chronic Obstructive Pulmonary Disease. Drug-Safety 7, 152–158 (1992). https://doi.org/10.2165/00002018-199207020-00006
Published:
Issue Date:
DOI: https://doi.org/10.2165/00002018-199207020-00006